139 related articles for article (PubMed ID: 21359906)
1. Day-to-day discrepancy in Bravo pH monitoring is related to the degree of deterioration of the lower esophageal sphincter and severity of reflux disease.
Ayazi S; Hagen JA; Zehetner J; Banki F; Augustin F; Ayazi A; DeMeester SR; Oh DS; Sohn HJ; Lipham JC; DeMeester TR
Surg Endosc; 2011 Jul; 25(7):2219-23. PubMed ID: 21359906
[TBL] [Abstract][Full Text] [Related]
2. 24-h multichannel intraluminal impedance-pH monitoring may be an inadequate test for detecting gastroesophageal reflux in patients with mixed typical and atypical symptoms.
Han MS; Lada MJ; Nieman DR; Tschoner A; Peyre CG; Jones CE; Watson TJ; Peters JH
Surg Endosc; 2015 Jul; 29(7):1700-8. PubMed ID: 25398192
[TBL] [Abstract][Full Text] [Related]
3. Safety and tolerability of transoral Bravo capsule placement after transnasal manometry using a validated conversion factor.
Lacy BE; O'Shana T; Hynes M; Kelley ML; Weiss JE; Paquette L; Rothstein RI
Am J Gastroenterol; 2007 Jan; 102(1):24-32. PubMed ID: 17100980
[TBL] [Abstract][Full Text] [Related]
4. Esophageal pH monitoring with the BRAVO capsule: experience in a single tertiary medical center.
Cabrera J; Davis M; Horn D; Pfefferkorn M; Croffie JM
J Pediatr Gastroenterol Nutr; 2011 Oct; 53(4):404-8. PubMed ID: 21519281
[TBL] [Abstract][Full Text] [Related]
5. Wireless ambulatory pH studies: manometric or endoscopic guidance?
Nusrat S; Roy PM; Bielefeldt K
Dis Esophagus; 2012 Jan; 25(1):26-32. PubMed ID: 21676068
[TBL] [Abstract][Full Text] [Related]
6. Wireless capsules for esophageal pH monitoring: are we placing them correctly?
Doma S; Paladugu S; Parkman HP; Friedenberg FK
Digestion; 2010; 82(1):54-9. PubMed ID: 20215751
[TBL] [Abstract][Full Text] [Related]
7. Nonendoscopic transnasal placement of a wireless capsule for esophageal pH monitoring: feasibility, safety, and efficacy of a manometry-guided procedure.
Marchese M; Spada C; Iacopini F; Familiari P; Shah SG; Tringali A; Costamagna G
Endoscopy; 2006 Aug; 38(8):813-8. PubMed ID: 17001571
[TBL] [Abstract][Full Text] [Related]
8. New esophageal function testing (impedance, Bravo pH monitoring, and high-resolution manometry): clinical relevance.
Wilson JA; Vela MF
Curr Gastroenterol Rep; 2008 Jun; 10(3):222-30. PubMed ID: 18625130
[TBL] [Abstract][Full Text] [Related]
9. Day-to-day variability in acid reflux patterns using the BRAVO pH monitoring system.
Ahlawat SK; Novak DJ; Williams DC; Maher KA; Barton F; Benjamin SB
J Clin Gastroenterol; 2006 Jan; 40(1):20-4. PubMed ID: 16340628
[TBL] [Abstract][Full Text] [Related]
10. Impact of prolonged 48-h wireless capsule esophageal pH monitoring on diagnosis of gastroesophageal reflux disease and evaluation of the relationship between symptoms and reflux episodes.
Domingues GR; Moraes-Filho JP; Domingues AG
Arq Gastroenterol; 2011; 48(1):24-9. PubMed ID: 21537538
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure: one- and 2-year results of a feasibility trial.
Bonavina L; DeMeester T; Fockens P; Dunn D; Saino G; Bona D; Lipham J; Bemelman W; Ganz RA
Ann Surg; 2010 Nov; 252(5):857-62. PubMed ID: 21037442
[TBL] [Abstract][Full Text] [Related]
12. Obesity and gastroesophageal reflux: quantifying the association between body mass index, esophageal acid exposure, and lower esophageal sphincter status in a large series of patients with reflux symptoms.
Ayazi S; Hagen JA; Chan LS; DeMeester SR; Lin MW; Ayazi A; Leers JM; Oezcelik A; Banki F; Lipham JC; DeMeester TR; Crookes PF
J Gastrointest Surg; 2009 Aug; 13(8):1440-7. PubMed ID: 19475461
[TBL] [Abstract][Full Text] [Related]
13. 48-Hour pH monitoring increases the risk of false positive studies when the capsule is prematurely passed.
Iqbal A; Lee YK; Vitamvas M; Oleynikov D
J Gastrointest Surg; 2007 May; 11(5):638-41. PubMed ID: 17468923
[TBL] [Abstract][Full Text] [Related]
14. Role of the lower esophageal sphincter on acid exposure revisited with high-resolution manometry.
Hoshino M; Sundaram A; Mittal SK
J Am Coll Surg; 2011 Dec; 213(6):743-50. PubMed ID: 22107919
[TBL] [Abstract][Full Text] [Related]
15. Bravo (wireless) ambulatory esophageal pH monitoring: how do day 1 and day 2 results compare?
Bechtold ML; Holly JS; Thaler K; Marshall JB
World J Gastroenterol; 2007 Aug; 13(30):4091-5. PubMed ID: 17696227
[TBL] [Abstract][Full Text] [Related]
16. Esophagogastric Junction Morphology and Distal Esophageal Acid Exposure.
Akimoto S; Singhal S; Masuda T; Yamamoto SR; Svetanoff WJ; Mittal SK
Dig Dis Sci; 2016 Dec; 61(12):3537-3544. PubMed ID: 27730315
[TBL] [Abstract][Full Text] [Related]
17. [Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD)].
Mönkemüller K; Neumann H; Fry LC; Kolfenbach S; Malfertheiner P
Z Gastroenterol; 2009 Apr; 47(4):351-6. PubMed ID: 19358061
[TBL] [Abstract][Full Text] [Related]
18. 24 Versus 48-hour bravo pH monitoring.
Chander B; Hanley-Williams N; Deng Y; Sheth A
J Clin Gastroenterol; 2012 Mar; 46(3):197-200. PubMed ID: 21959323
[TBL] [Abstract][Full Text] [Related]
19. Basal lower esophageal sphincter pressure in gastroesophageal reflux disease: An ignored metric in high-resolution esophageal manometry.
Jain M; Srinivas M; Bawane P; Venkataraman J
Indian J Gastroenterol; 2018 Sep; 37(5):446-451. PubMed ID: 30402679
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic and manometric position-related characteristics of the normal gastroesophageal junction.
Buduhan G; Orlina J; Louie B; Vallieres E; Aye R
Surg Endosc; 2010 Sep; 24(9):2165-9. PubMed ID: 20174938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
